AbbVie Golden Tickets will be awarded to two early-stage companies

Companies who develop novel, transformational therapies for:

  • Immunology

  • Oncology

  • Neuroscience

  • Eye Care

  • Aesthetics

Winners will receive:

  • One year of free lab space and access to shared amenities and services provided by MBC BioLabs in San Francisco or San Carlos.
  • Opportunities to engage with AbbVie scientific and business leaders.

To apply, please email your non-confidential company presentation to by October 19th, 2021.

In the application, please address:

  • What is the scientific insight and approach driving your company?
  • If successful, how would your therapeutic approach provide significant patient benefit beyond currently available treatment or other R&D stage programs?

Selected applicants will be invited to present their company to an expert AbbVie leadership panel at an event to be held virtually on December 2nd, 2021.

We look forward to receiving your application. Contact us with any questions at or